Healthcare provider profile · identity verified

Zakia Nuruddin, MD

Family Practice · HOUSTON, TX · NPI 1407935786

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	172
Amlodipine Besylate	Amlodipine Besylate	266	113
Alendronate Sodium	Alendronate Sodium	240	73
Levothyroxine Sodium	Levothyroxine Sodium	238	96
Simvastatin	Simvastatin	208	82
Gabapentin	Gabapentin	182	61
Metformin Hcl	Metformin Hcl	173	71
Lisinopril	Lisinopril	149	64
Losartan Potassium	Losartan Potassium	146	60
Omeprazole	Omeprazole	122	48
Hydrochlorothiazide	Hydrochlorothiazide	102	46
Fluticasone Propionate	Fluticasone Propionate	90	35
Metoprolol Succinate	Metoprolol Succinate	89	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	32
Rosuvastatin Calcium	Rosuvastatin Calcium	85	35
Trazodone Hcl	Trazodone Hcl	80	28
Pravastatin Sodium	Pravastatin Sodium	67	25
Albuterol Sulfate Hfa	Albuterol Sulfate	66	28
Escitalopram Oxalate	Escitalopram Oxalate	63	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	23
Ozempic	Semaglutide	62	16
Carvedilol	Carvedilol	56	24
Furosemide	Furosemide	56	21
Metoprolol Tartrate	Metoprolol Tartrate	56	27
Pantoprazole Sodium	Pantoprazole Sodium	54	24
Tizanidine Hcl	Tizanidine Hcl	52	21
Citalopram Hbr	Citalopram Hydrobromide	51	22
Baclofen	Baclofen	50	19
Clopidogrel	Clopidogrel Bisulfate	50	19
Jardiance	Empagliflozin	50	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	21
Allopurinol	Allopurinol	47	16
Montelukast Sodium	Montelukast Sodium	47	16
Atenolol	Atenolol	44	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	17
Nifedipine Er	Nifedipine	44	19
Tamsulosin Hcl	Tamsulosin Hcl	44	19
Mirtazapine	Mirtazapine	41	15
Potassium Chloride	Potassium Chloride	39	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	14
Buspirone Hcl	Buspirone Hcl	38	15
Triamcinolone Acetonide	Triamcinolone Acetonide	37	22
Sertraline Hcl	Sertraline Hcl	31	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	11
Olmesartan Medoxomil	Olmesartan Medoxomil	29	12
Celecoxib	Celecoxib	27	suppressed
Eliquis	Apixaban	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	14
Alprazolam	Alprazolam	24	suppressed
Methylprednisolone	Methylprednisolone	23	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	20
Nystatin	Nystatin	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Famotidine	Famotidine	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	17	suppressed
Prednisone	Prednisone	17	14
Valacyclovir	Valacyclovir Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Estradiol	Estradiol	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glipizide	Glipizide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error